Related Experiment Videos
Summary
Spironolactone can cause gynecomastia (breast enlargement in men), a reversible side effect. Patients should be informed about this risk before starting spironolactone therapy.
Area of Science:
- Endocrinology
- Pharmacology
Context:
- Drug-induced side effects
- Gynecomastia in adult males
Purpose:
- To report drug-induced gynecomastia cases linked to spironolactone
- To discuss the mechanism of spironolactone-induced gynecomastia
Summary:
- Four male patients aged 41-69 developed gynecomastia while on spironolactone.
- Gynecomastia resolved after discontinuing spironolactone.
- Spironolactone's mechanism involves altering the androgen-estrogen ratio and peripheral antiandrogenic effects.
Impact:
- Highlights the importance of patient education regarding spironolactone side effects.
- Informs clinical practice on managing potential endocrine disturbances caused by spironolactone.